Search Results

Denise Wootten and Patrick Sexton on class B GPCR pharmacology and biased agonism at the GLP-1 receptor Following the Question, Not the Credential Zhao describes her decision to pursue a postdoc as emerging understand" 19:38 Why Australia - how a single conference in Melbourne redirected the next chapter 22:28 The decision

. - Yamina will attempt to book Denise for a future podcast episode. Towards the end, they focused on Arthur's transition to become Dean and his decision to move from Australia Postdoctoral Position, Scientific Dynamics, and New Drug Targets Arthur shared his decision to undertake The conversation also touched upon Arthur's career decisions, his scientific achievements, and the importance

. - Yamina will attempt to book Denise for a future podcast episode. Towards the end, they focused on Arthur's transition to become Dean and his decision to move from Australia Postdoctoral Position, Scientific Dynamics, and New Drug Targets Arthur shared his decision to undertake The conversation also touched upon Arthur's career decisions, his scientific achievements, and the importance

Biotech Leaders & Scientists Actionable Data Insights: Translate complex GPCR pharmacology into clear decisions to remove roadblocks, enhance execution, and generate actionable scientific data, driving confident decisions This partnership prevents bottlenecks and optimizes resource allocation, ensuring every strategic decision This ensures robust, defensible decisions that de-risk your program from early discovery to regulatory Yamina brings the clarity, rigor, and structured decision-making that keeps programs on track.

Take your idea, platform, or early data and turn it into a strategic roadmap with clear decisions, timelines How I Help Biotechs Accelerate GPCR Discovery with Clarity, Speed & Confidence Decisions, Not More Data Prioritize assays based on project phase and decision points Map go/no-go logic that guides program momentum confidence Trusted by Biotech Innovators Before working with Yamina, we were navigating challenging decisions You walk away with a decision-ready roadmap, improved CRO output, and faster movement through your discovery

Home About Services News Get in Touch Welcome VC Insights Fast Track Your Next Biotech Bet Get decision-grade Translate project strategy into clear decision-driving assays Eliminate “nice to have” tests that stall I bring structure, decision frameworks, and momentum so your team stays on track. I’ve worked with her on several discovery programs; in fragmented programs, she brought clarity and decision

Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

“The data looks fine, but it doesn’t help us make decisions.” and reduce delays • Align teams across roles—from assay execution to client updates Data Turns Into Decisions—Not science into clear deliverables • Define program objectives and guide assay plans that support partner decisions

for Biotech Growth Operational System Design (OS) Cross-functional Team Alignment Scaling Protocols & Decision In reality, something more subtle starts to shift. 👉 Decision-making changes.

Walk away with something you can apply in your next experiment, assay, or project decision. system choice does to bias estimates Translating pathway-level data into lead selection and optimization decisions Why potency alone is not enough for candidate-level decisions 📅 May 28, 2026 at 3:00:00 PM Details

.” — Alex Serafini Decision-Making: Saying Yes to the Unorthodox Path Serafini’s journey defied traditional His approach to decision-making is pragmatic: follow impact, not orthodoxy. The decision to stay on as a postdoc in the same lab as his PhD — with Dr.

This session addresses the structural and strategic decisions that determine whether breakthrough science

Family First, Always The decision to shift from academia to industry wasn’t driven by disillusionment—it This pragmatic decision led him to high-throughput screening at DuPont, proving that scientific ambition

Valuable and Accessible Property of New Drug Candidates Turning functional selectivity into a practical decision-making out loud, and where receptor theory, biased signaling, and the pharmacology of real drug discovery decisions

I want to connect more trainees with diverse career resources to support professional decision-making opportunities of my peers, in combination with my own scientific endeavors, will inform my future career decisions

ortholog connections - from fly adhesion GPCRs to vertebrate vascular and neurological disease Career decisions The decision to stay came from a specific opportunity, a specific mentor, and a specific set of questions Introduction of Beatriz Blanco-Redondo; icebreaker 01:15 - Career path: from Spain to Germany, and the decision

Science Journey and Postdoc Decision Mike discussed his journey into science and his decision to pursue Career Trajectory and Faculty Position Yamina and Mike discussed Mike's career trajectory and his decision

Partner perks: Direct interaction with researchers, founders, and decision‑makers Access to all member

Decision-Making: From Researcher to Scientific Leader Maria’s story is one of trusting her instincts I wasn’t sure at first, but I realized I could do this too.” — Maria Majellaro Her decisions, often made

scientists interpret pharmacology through the same frameworks, experiments become clearer and program decisions

scale 10:16 Lessons for the next one, and the shape of the new normal Selected Quotes "So we made a decision Montreal being the epicenter of the disease in this country — we don't regret that decision now."

Kenakin's weekly insights and AMAs — building shared language around GPCR data and pharmacological decisions

evaluating CROs, platforms, or tools Use ecosystem visibility to support commercial conversations and decision-making

target and delivering a drug, the challenges of target validation, and the realities of industrial decision-making The CGRP story illustrates how structural biology and pharmacology intersect with corporate decisions

He discusses his formative scientific experiences, critical decision points moving from academia into

and GPCR Data Analysis For most of GPCR pharmacology's history, affinity was the number that drove decisions off-rate aha moment: seven hours on the receptor versus fifteen minutes 52:22 Founding PharmaChanics: the decision

This allows Hauser to study GPCR variant effects in the context of real prescribing decisions, not controlled ethics of population-scale research 10:14 - Origin story - hospital internship, Australia, and the decision

chemistry to pioneering peptide–fluorophore conjugates for the GLP-1 receptor, JB breaks down the strategic decisions